NR 566 Midterm Exam Study Guide: Key Concepts & Practice Questions, Exams of Nursing

Download NR 566 Midterm Exam Study Guide: Key Concepts & Practice Questions and more Exams Nursing in PDF only on Docsity! NR 566 Week 1 - 3 Midterm Exam Comprehensive Exam Study Guide Latest Updated 2024/2025 . The Best Study Notes NR 566 Week 1 - 3 Midterm Exam Comprehensive Exam Study Guide Latest Updated 2024/2025 NR 566 Week 1 - 3 Midterm Exam Week 1 Professor question: Why are statins recommended in the evening instead of morning? (pg 561) After starting John on insulin, he calls the office saying he feels bad. He said when he checked his blood sugar before calling it was 52 mg/dl. What instructions should he be given? Answer from classmate: Statins are recommended to be taken in the evening. Cholesterol synthesis is highest through the night and first thing in the morning. The biosyntheses of cholesterol follows a normal circadian rhythm. Administration at night allows for the medication to be at peak levels in the body during the time of high cholesterol synthesis (Korani et al., 2019). A blood glucose level <70mg/dL is considered to be hypoglycemia. John called the office with a sugar of 52mg/dL. He would be given instructions that follow "the rule of 15". This means that when symptoms occur, he should consume 15 g of a fast-acting carbohydrate. After 15 minutes, he should recheck his blood glucose. John should also be educated on the best options of carbohydrates to consume. Examples would be 4 oz of juice, four-five hard candies, honey, or half a can of regular soft drink. Another education point is that John needs to have a meal within a few hours after the low blood glucose. He may also need to see his doctor for adjustments to be made on insulin dosage as well as meal patterns to help prevent another low blood glucose episode from occurring (Woo & Robinson, 2016). Professor question: What diabetic medications would be contraindicated in patients with heart failure? Which diabetic drug(s) may have beneficial effects in heart failure? (text has info on this but ADA 2020 guidelines has even more up to date info on this topic, so here is the page. See Recommendation 9.9 and 9.10) https://care.diabetesjournals.org/content/43/Supplement_1/S98 answer from classmate: Suppose John was showing signs of heart failure. What diabetic medications would be contraindicated in patients with heart failure? Metformin is contraindicated in patients with renal insufficiency and unstable heart NR 566 Week 1 - 3 Midterm Exam Comprehensive Exam Study Guide Latest Updated 2024/2025 • Initiation of therapy is not recommended in patients with eGFR between 30 –45 mL/minute/1.73 m² • Obtain an eGFR at least annually in all patients receiving therapy • In patients at increased risk for development of renal impairment (e.g., the elderly), renal function should be assessed more frequently NR 566 Week 1 - 3 Midterm Exam Comprehensive Exam Study Guide Latest Updated 2024/2025 • If eGFR later falls below 45 mL/minute/1.73 m², assess benefit and risk of continuing therapy Iodinated contrast imaging procedures • Discontinue metformin at the time of or before an iodinated contrast imaging procedure in patients with an eGFR between 30-60 mL/minute/1.73 m²; in patients with a history of liver disease, alcoholism, or heart failure; or in patients who will be administered intra-arterial iodinate contrast • Reevaluate eGFR 48 hr after the imaging procedure; restart metformin if renal function is stable" • https://reference.medscape.com/drug/glucophage-metformin-342717 Professor question: The GLP1RA class drugs end with "-tide". They are highly recommended as a second agent after metformin by both ADA and AACE/ACE guidelines. Per ADA guidelines: • 9.9 Among patients with type 2 diabetes who have established atherosclerotic cardiovascular disease or indicators of high risk, established kidney disease, or heart failure, a sodium–glucose cotransporter 2 inhibitor or glucagon-like peptide 1 receptor agonist with demonstrated cardiovascular disease benefit (Table 9.1 (Links to an external site.), Table 10.3B (Links to an external site.), Table 10.3C (Links to an external site.)) is recommended as part of the glucose-lowering regimen independent of A1C and in consideration of patient-specific factors (Figure 9.1 (Links to an external site.)). A • 9.10 In patients with type 2 diabetes who need greater glucose lowering than can be obtained with oral agents, glucagon-like peptide 1 receptor agonists are preferred to insulin when possible. B Unfortunately these agents are very expensive, from about $700-1,200/month which will make them unaffordable for many patients if insurance does not cover the cost. It is such a shame that cost factors into prescribing! according to the text, what effect does carbamazepine have on thyroid function tests? What is the difference b/w total and free T4? P 1181 Table 41-1 NR 566 Week 1 - 3 Midterm Exam Comprehensive Exam Study Guide Latest Updated 2024/2025 Answer from classmate: According to the text, carbamazepine decreases the serum concentration of thyroid hormones. It is proposed that carbamazepine increases the extra-thyroidal metabolism of thyroid hormones (Woo & Robinson, 2016). Total T4 measures the bound and free thyroid hormone and can change when binding proteins NR 566 Week 1 - 3 Midterm Exam Comprehensive Exam Study Guide Latest Updated 2024/2025 Classmate answer: Wow, I am glad you brought that to my attention. I work in the emergency room and have heard radiology give the speech over and over. It usually goes something like "don't take your glucophage for 48 hours because it binds with the dye and makes it harder to pass" and they hand them a piece of paper that tells them when to start taking it again. Now I know this is not the case. In the emergency room we check the patient's kidney function prior to giving the contrast. We have an acceptable range for non diabetic patients and a range for diabetic patients. On occasion we give IV contrast to patients with poor kidney function with the understanding that they will have dialysis afterwards. "There is controversy about the causal relationship between exposure to IV CM and PC-AKI" (Van der Molen et. al, 2018). In the ER setting there is no follow up to check kidney function post IV contrast. It has been mentioned that the patient can start their glucophage after 48 hours as long as kidney function remains acceptable but this seems like a step that is skipped. Making sure the patient is hydrated seems to be emphasized more, either through PO or IV routes. This will help maintain proper kidney function after receiving IV contrast. Professor question: Can you review for us what the ADA criteria for diagnosis of T2DM are? Classmate answer: The ADA diagnoses T2DM based on several criteria. The patient may have a fasting glucose of 126mg/dL (7.0 mmol/L) or higher. A 2-hour plasma glucose level of 200 mg/dL (11.1 mmol/L) or higher in the midst of a 75-g oral glucose clearance test. Also, a random plasma glucose of 200mg/dL (11.1 mmol/L) or higher with a patient that is also displaying signs of hyperglycemia or that they maybe in a hyperglycemic crisis. And lastly, the patient has a hemoglobin A1c level of 6.5% (48 mmol/dL) or higher (ADA, 2020). Professor question: If John’s A1C remains elevated and he does not have any indicators or at high-risk for ASCVD, CKD, or HF, a thiazolidinedione (TZD) could be prescribed (American Diabetes Association, 2020). How do thiazolidinediones help control blood sugar? Why is it important that there is little to no risk indicators for cardiovascular involvement when prescribing TZDs? pg 581-2 Classmate answer: Pioglitazone (Actos) and rosiglitazone (Avandia) are the two thiazolidinedione (TZD) that are available in the United States. TZD’s help by improving insulin sensitivity. The presence of insulin is needed for TZD’s to work which makes them ideal in the management of Type II Diabetics. TZD’s act on the peroxisome proliferator-activated receptor gamma. This receptor helps regulate gene transcription resulting in expression of proteins that improve insulin action in the cell. This mechanism of action provides an increased utilization of available insulin by the liver and muscle cells as well as that in adipose tissue (Micromedex, 2020). NR 566 Week 1 - 3 Midterm Exam Comprehensive Exam Study Guide Latest Updated 2024/2025 TZD’s prescription use is contraindicated in patients with NYHA class III or IV heart failure. Initiating or increasing dose of TZD’s requires the observation of any possible signs of heart failure. Heart failure signs and symptoms can include, rapid weight gain, dyspnea, and edema (Teri Moser Woo Phd Aprn Cnl Cpnp-pc Faanp et al., 2015, p. 581). NR 566 Week 1 - 3 Midterm Exam Comprehensive Exam Study Guide Latest Updated 2024/2025 Professor question: One class of diabetic drugs sometimes used is meglitinides. What is an important teaching point about this drug for patients to make sure the drug is most effective? pg 585 table 21-22 classmate answer: Hello Professor and class, what I gather from the readings is that Meglitinides may be given in conjunction with Metformin. Research states that Meglitinides should be given within 15 to 30 minutes before eating. I the patient is not going to eat, then this medication should not be taken. Also, this medication is not to replace any current medications. The patient also needs to monitor glucose regularly (Pakkir, 2018). Professor question: What side effects are most common for GLP-1 receptor agonists? What diseases would be contraindicated to have with the administration of GLP-1 receptor agonists? pg596 classmate answer: Glucagon-like peptide 1 receptor agonists (GLP-1RAs) are beneficial in the treatment of type 2 diabetes due to their glucose-lowering effects. Examples of GLP-1RAs are lixisenatide, liraglutide, exenatide, semaglutide, and dulaglutide. However, GLP-1RAs may cause side effects with some being serious. Common side effects include nausea, diarrhea, vomiting, headaches, mild tachycardia, headaches, dizziness, and dyspepsia (Collins & Costello, 2020). Rare side effects such as the development of pancreatitis and thyroid C-cell tumors have also been reported (Hinnen, 2017). Close monitoring is thus necessary to prevent the development of adverse effects. Owing to such side effects, healthcare professionals should consider certain contraindications when selecting GLP-1RAs. Notably, some animal studies have shown thyroid C-cell hyperplasia, medullary thyroid carcinomas, and adenomas with the use of some GLP-1RAs such as liraglutide in mice (Hinnen, 2017; Collins & Costello, 2020). As such, GLP-1RAs are contraindicated in individuals with a family or personal history of medullary thyroid carcinoma as well as among those with multiple endocrine neoplasia syndrome type 2 (Hinnen, 2017). GLP-1RAs should also be used with caution in those with severe gastroesophageal reflux disease, inflammatory bowel disease, and gastroparesis (Hinnen, 2017). The medication is also contraindicated in cases of hypersensitivity and pregnancy (Collins & Costello, 2020). Discontinuation of GLP-1RA therapy is, therefore, necessary if patients receiving this medication develop the contraindicated diseases or conditions. NR 566 Week 1 - 3 Midterm Exam Comprehensive Exam Study Guide Latest Updated 2024/2025 Professor FACTS: The current IDSA guidelines (2019) recommend the following 3 options when treating CAP in a previously healthy patient: 1. Beta-lactam (eg high dose Amox) 2. Doxycycline NR 566 Week 1 - 3 Midterm Exam Comprehensive Exam Study Guide Latest Updated 2024/2025 3. Macrolide (if the resistance in the community is not too high). If a patient has comorbidities (eg DM, COPD) or recent antibiotic use, the recommendation is to use one of the following options: 1. A respiratory fluoroquinolone Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America https://www.atsjournals.org/doi/full/10.1164/rccm.201908-1581ST (Links to an external site.) 2. Beta-lactam plus either doxy or a macrolide Prednisone should not be prescribed routinely for viral or bacterial pneumonia. Guidelines recommend use in the severely ill ICU patient. Classmate response: I followed the link to the American Thoracic Society and Infectious Diseases Society of American and reviewed the current official clinical practice guidelines for treating an otherwise healthy adult with community-acquired pneumonia. Previously, when researching, I believe I used articles found within our Chamberlain Library. After reviewing the official clinical practice, I see that the first line of treatment would be high dose Amoxicillin, doxycycline, or like I listed above, a macrolide antibiotic. One of the primary reasons I mentioned prednisone as an additional treatment option is due to reflection of past experience. It is good to see that in the official clinical practice guidelines, that is not routinely prescribed for viral or bacterial pneumonia. I have been prescribed a respiratory fluoroquinolone, levofloxacin, in the past to treat pneumonia. Levofloxacin is generally a safe, well-tolerated, broad-spectrum antibiotic that has a good pharmacodynamic profile and pharmacokinetic profile, and exhibits low potential for resistance against S. pneumoniae (Metlay, et al., 2019). Important patient teaching for levofloxacin includes the risk that the patient will develop tendonitis or a tendon rupture during the course of treatment or for several months after treatment. It is the recommendation of the FDA that at the first sign of tendon pain, swelling, or inflammation, patients should discontinue the levofloxacin, avoid exercise, and use of the affected area, and contact their provider immediately for a tendon evaluation as well as a change to a non-fluoroquinolone antibiotic (2016). While taking this medication it is important for patients to remain aware of their bodies so that they can quickly notice when there has been a change. Professor response to classmate: So glad you reviewed the guidelines! They just came NR 566 Week 1 - 3 Midterm Exam Comprehensive Exam Study Guide Latest Updated 2024/2025 out the end of last year. I was surprised that Amox made it into the guidelines, but it is related to resistance and that the higher dose can overcome that resistance. NR 566 Week 1 - 3 Midterm Exam Comprehensive Exam Study Guide Latest Updated 2024/2025 Acquired or secondary resistance occurs in a patient who has been previously treated for TB. Poorly or inadequately treated TB is the leading cause of secondary resistance. Extensively resistant TB (resistant to multiple second-line drugs) is resistant both to isoniazid and rifampin and to any fluoroquinolone drug and at least one of three second- line injectable drugs (amikacin, kanamycin, or capreomycin). Drug resistance can be proved only by susceptibility testing (Woo, & Robinson, 2016). If INH resistance is documented in a patient on a 9-month regimen (without PZA), then INH should be discontinued. If EMB was included in the initial regimen, then treatment with RIF and EMB should continue for a minimum of 12 months. If the initial treatment did not include EMB, then testing for drug susceptibility should be repeated, and INH needs to be discontinued and two new drugs should be added (Woo, & Robinson, 2016). The regimen may need to be adjusted when drug susceptibility test results are available. Any patient whose TB demonstrates resistance must be seen by an infectious disease specialist who treats patients with TB. Inadequate treatment is one of the leading causes of secondary resistant TB (Woo, & Robinson, 2016). Professor question: From our text can you tell us the findings of the SMART trial regaring salmeterol use? Classmate answer: The Salmeterol Multicentre Asthma Research Trial was a large random controlled trial in asthma patients that evaluated the safety of salmeterol use. The findings showed that a non-significant increase in combined respiratory-related deaths and/or life-threatening events found in patients using salmeterol. The SMART trial also had findings of a statistically significant increase of death and life-threatening situations among African American patients. According to Rottenkolber (2015), "a significantly increased risk for “combined respiratory-related death or life-threatening experience and combined asthma-related deaths or life-threatening experience was found for African Americans who had no prescription of inhaled corticosteroids at baseline." In the conclusion of the SMART trial contrast, at baseline no significant differences between patients receiving salmeterol or placebo were found in the results as well as previous and current published guidelines. Long-acting beta-2-agonist was recommended to be prescribed only to patients receiving inhaled corticosteroids. After results were given to the public, according to Rottenkolber (2015), "information for health care providers were sent out by the FDA stating that long-acting beta-2-agonist should be prescribed to asthma patients only if other medicines, including low-or- medium dose inhaled corticosteroids do not control asthma." The FDA imposed a Black NR 566 Week 1 - 3 Midterm Exam Comprehensive Exam Study Guide Latest Updated 2024/2025 box’ warning on long-acting beta-2-agonists. Professor question: According to our text, what is the advantage of using transdermal nicotine over nicotine gum? NR 566 Week 1 - 3 Midterm Exam Comprehensive Exam Study Guide Latest Updated 2024/2025 Classmate answer: The transdermal nicotine has its advantages over the use of nicotine gum. The patch delivers a constant level o f nicotine to help prevent the occurrence of withdrawal symptoms. When the patient uses the gum, they are putting something in their mouth which does not take away the behavioral aspect of cigarette smoking. The oral aspect is not reinforced. The transdermal patch is also easier in the aspect of administration. Compared to gum that needs to be chewed anywhere from 20-30 times a day, the patch is applied once a day and the dose is of the patch is weaned on a scheduled basis (Woo & Robinson, 2016). Professor question: Theophylline is not used very often anymore but we may see it used by a specialist when inhaled therapy is insufficient. The reason is that this is a drug with a narrow therapeutic window- it is associated with toxicities including seizures. It is a drug that requires monitoring of drug levels. According to our text, are there any considerations regarding theophylline and type of diet? Classmate response: According to our textbook, theophylline can interact with beta- blockers because it can increase serum theophylline if taken together. Another interacting drug is the inhalation of anesthetics which can cause increased arrthymia. Smoking can increase theophylline clearance. A diet that is low in carbohydrates and high in protein can decrease the elimination of the drug. A diet that is high in carbohydrates and low in protein causes the drug to lengthen its half-life. Charcoal broiled foods should be avoided because it accelerates the hepatic metabolism of the drug. Any caffeine elimination may be increased as well. Theophylline considerations include monitoring closely for any signs of toxicity as well as frequent levels need to be checked when a new medication is being added. Signs of toxicity include any jitteriness, headaches, rashes, restlessness, convulsions, nausea and vomiting (Woo & Robinson, 2016). Professor question: If a woman is pregnant and taking INH, what supplement do we need to advise? (see text) Classmate answer: Pregnant women who are taking INH need to be prescribed Pyridoxine (vitamin B6) 25mg/d to decrease the incidence of peripheral neuropathy which is linked to patients taking INH Professor question: What type of medication is Spiriva? What is the generic name? NR 566 Week 1 - 3 Midterm Exam Comprehensive Exam Study Guide Latest Updated 2024/2025 Fenofibric acid is an antilipemic drug that is categorized as a fibric acid derivative. Fibric acids such as fenofibric acid are potent ligands of peroxisome proliferator receptor alpha (PPAR- α), which plays an important role in fatty acid metabolism regulation (Mathew & Singh, 2020). I will address this role in the next paragraph which focuses on NR 566 Week 1 - 3 Midterm Exam Comprehensive Exam Study Guide Latest Updated 2024/2025 how fenofibric acid works. Fenofibric acid is usually utilized as an adjunct to diet therapy to lower triglyceride levels in adults diagnosed with severe hypertriglyceridemia (Alagona Jr, 2010). Another use regards lowering of elevated total cholesterol, triglycerides, alipoprotein B, and LDL and to increase high-density lipoproteins (HDLs) in individuals with mixed dyslipidemia or hypercholesterolemia (Alagona Jr, 2010). Fenofibric acid can also be used to lower hypertriglyceridemia (HTG) to decrease pancreatitis risk (Scherer et al., 2014). Notably, fenofibric acid can be used alone or in combination therapy with statins. The drug is available in several brand names including Trilipix, Lipofen, and Antara among others. To understand how fenofibric acid works, we have to understand its mechanism of action. Clinical studies have demonstrated that fenofibric acid works by activating PPAR- α (Alagona Jr, 2010). PPAR-α is a transcription factor involved in the regulation of multiple genes with activation by an agonist resulting in increased gene transcription and protein synthesis (Mathew & Singh, 2020). Likewise, fenofibric acid binds to PPAR- α thereby activating it. Consequently, lipolysis as well as triglyceride-rich particles elimination from plasma increase (Mathew & Singh, 2020). This happens because of the activation of lipoprotein lipase and a curtailment of the production of apoprotein C- III, which is a known inhibitor of lipoprotein lipase activity (Alagona Jr, 2010). With the consequent reduction in triglycerides, the size and composition of low-density lipoproteins (LDLs) are altered since small-LDL particles are eliminated resulting in low LDL levels. (Alagona Jr, 2010). Furthermore, PPAR- α results in an induction of increased HDL through the upregulation of apoproteins apo A-I, and apo A-II (Alagona Jr, 2010). Fenofibric acid, therefore, realizes its benefits through multiple mechanisms. As indicated earlier, fenofibric acid is used to reduce HTG to lower the risk of pancreatitis. However, it must be noted that indications for this benefit are for those with severe hypertriglyceridemia because not all patients with hypertriglyceridemia are at risk of developing pancreatitis (Chait & Subramanian, 2019). The rationale is that there is a 5% and 10-20% pancreatitis risk in individuals with serum triglycerides >1000mg/dl and >2000 mg/dl respectively (Scherer et al., 2014). The Endocrine Society considers HTG levels 1000-1999 mg/dl as severe and levels ≥2000 mg/dl as very severe (Berglund et al., 2012). Since pancreatitis risk is highest in severe and very severe HTG, it is reasonable to argue that these are the levels of HTG when fenofibric acid should be considered to lower pancreatitis risk (Scherer et al., 2014; Chait & Subramanian, 2019). Nevertheless, secondary causes of HTG should be addressed before initiating fenofibric acid therapy. Maintaining low triglyceride levels is necessary to prevent recurrent pancreatitis. Professor question: Thanks! To help with our topic of lipid management this week, what lab test should we order if a patient on a statin develops muscle pain? NR 566 Week 1 - 3 Midterm Exam Comprehensive Exam Study Guide Latest Updated 2024/2025 Classmate answer: One of the most common adverse reaction with statin use is muscle pain. It can be defined based on a spectrum of severity that includes myalgia, myopathy, myositis, myonecrosis, and rhabdomyolysis. The risk factors for this to occur NR 566 Week 1 - 3 Midterm Exam Comprehensive Exam Study Guide Latest Updated 2024/2025 Classmate answer: In a patient with heart failure prescribing Calcium Channel Blockers (CCB) can reduce the ejection fraction of the heart, second or third-degree AV blockade, and sick sinus syndrome because of the possibility of causing bradycardia and worsening cardiac output. In a study of 2,466 patient with recent myocardial infarction randomized to diltiazem or placebo, the patient that took diltiazem increased the risk of adverse cardiac events. These drugs may exacerbate the disease. Verapamil has the most pronounced negative inotropic effect and needs to be avoided in Heart Failure patients and it also can worsen the disorder (Tang, 2018). Verapamil also has the strongest nodal conduction and make bradycardia worse. Patients that have ventricular dysrhythmias, and conduction disturbances in the SA or AV, patients who have systolic blood pressures below 90 mmHg because of the high risk for induction of heart failure and severe hypotension if prescribed CCB (Woo & Robinson, 2016). Professor question: Can you review the discussion of angina which discusses imbalance between myocardial oxygen supply (MOS) and demand (MOD) in the myocardium. Which of the following drugs affect MOS? Which affect MOD? Classmate answer: Angina is a syndrome that is characterized by the patient reporting a deep, poorly localized chest or arm pain that is associated with physical exertion or emotional stress (Woo & Robinson, 2016, p. 881). The patient will feel immediate relief with either rest or nitroglycerin. The cause of this angina is an imbalance between myocardial oxygen supply (MOS) and myocardial oxygen demand (MOD). Ischemia (angina) occurs when demand exceeds supply. There are multiple medication regimens that we can provide to the patient to help the supply and the demand of the heart. Nitrates Nitrates affect the myocardial oxygen supply and myocardial oxygen demand. Low dose nitroglycerin⟶⟶ dilate veins (more than arteries) venous return to the heart L-ventricular end diastolic pressure (preload) results in decreased wall tension and increased transmyocardial gradient increased oxygen supply to the myocardium relieve angina pain (Woo & Robinson, 2016). Beta Blockers Beta blockers work to help the myocardial oxygen demand of angina. Beta blockers decrease myocardial contractility force decrease heart rate and conduction velocity decrease systemic vascular resistance decrease blood pressure (afterload) reduce MOD relieve angina pain (Woo & Robinson, 2016, p.884). NR 566 Week 1 - 3 Midterm Exam Comprehensive Exam Study Guide Latest Updated 2024/2025 CCB CCB work on the MOD side of angina. NR 566 Week 1 - 3 Midterm Exam Comprehensive Exam Study Guide Latest Updated 2024/2025 Calcium into cells blocked dihydropyridines cause arterial smooth muscle relaxation results in peripheral vasodilation results in decrease afterload decreased MOD (Woo & Robinson, 2016, p. 884). • Non-dihydropyridine CCB (verapamil and diltiazem) reduce the SA node rate of depolarization and slow AV conduction which results in lowering heart rate in the smooth muscle of the heart (Woo & Robinson, 2016). These two actions will also effect the myocardium oxygen demand. ACE inhibitors Ace inhibitors work on angina by helping to solve the MOD and the MOS problems. Ace inhibitors block angiotensin II formation (vasoconstrictor) decreases peripheral vascular resistance decreased afterload decrease MOD (Woo & Robinson, 2016, p. 884). Coronary artery wall thickness is also reduced by the blocking of angiotensin II which will result in myocardium oxygen supply. Direct Renin Inhibitors (DRIs) DRI work to help reduce MOD in angina. The only approved DRI is Aliskiren (Tekturna). This medication will provide the patient with less cough and angioedema risk factors then patients who take ACE inhibitors. This medication is contraindicated for pregnant women (Woo & Robinson, 2016). DRIs decrease plasma renin activity block conversion of angiotensinogen to angiotensin I decrease angiotensin I decrease conversion of angiotensin II which decreases peripheral vascular resistance decrease MOD (Woo & Robinson, 2016, p. 884). ASA Since angina is mainly from atherosclerosis which causes vasodilation and plaque buildup. ASA helps stop the formation of thromboxane A2 in the formation of platelets. This helps in the fight to stop platelet buildup. ASA 81 to 162 mg are recommended for patients with angina (Woo & Robinson, 2016). Statin’s should also be included in the treatment regimen for angina. By reducing the patients LDL cholesterol, the patient will begin to have a decrease in atherosclerotic plaque which is causing the narrowing of the arteries which causes the ischemia (angina) (Woo & Robinson, 2016). NR 566 Week 1 - 3 Midterm Exam Comprehensive Exam Study Guide Latest Updated 2024/2025 shown that LDL levels may rise but not affect HDL levels with omega 3 FA treatment (Woo & Robinson, 2015). NR 566 Week 1 - 3 Midterm Exam Comprehensive Exam Study Guide Latest Updated 2024/2025 Professor question: To help with this week's study can you review from the text the causes of systolic heart failure? Classmate answer: According to the text, Woo & Robinson (2015), systolic heart failure or left ventricular dysfunction is due to an injury to the myocardium, in two thirds of patients, the cause is coronary artery disease (CAD) . Other causes of left ventricular dysfunction is a myocardial infarction (MI) or non-ischemic cardiomyopathy from drugs or chemotherapy that weaken the myocardium. The injury to the myocardium leads to hypertrophy or the thickening of the myocardium wall which then results in the decreased cardiac output or systolic heart failure(Woo & Robinson, 2015). Professor question: What is the dosing schedule for ACEIs? (how many times per day are they taken?) Classmate answer: Captopril is a short acting ACEI with a half-life of less than 2 hours; It requires 2-3 times daily dosing. All other members ACEIs are dosed once a day because they have a longer-half-life of 6 – 12 hours that require more time to achieve steady state. Losartan has a 2-hour half-life, and its active metabolite has a 6 to 9-hour half-life. Dosing may be daily or in two divided doses. Steady state is achieved in 3 to 6 weeks (Woo & Robinson, 2016). Professor question: According to the text, what labs should be checked in a week after initiating an ACEI? Why? Classmate answer: The labs that need to be checked in a week for patients who take ACE inhibitors are Serum Creatinine, BUN levels and electrolytes, particularly the potassium levels. ACE tends to increase the potassium levels causing hyperkalemia. This is when the levels are above 5.5. This will cause AKI (Acute Kidney Injury). If the levels of all 3 are elevated, then discontinuation of the ACE is needed. The labs need to be checked 1-2 weeks of initiation and after the dose is increased. If levels are stable, then the recheck can occur in 4 weeks. According to Woo & Robinson (2016), ACE inhibitors decrease proteinuria in those with CKD and help with blood pressure control. Adding an ACE inhibitor for patients with known CKD commonly results in increased serum creatinine. The improvement in proteinuria happens despite this effect. It is acceptable to have an 30% increase in SCr with the discontinuation of the ACE inhibitor. NR 566 Week 1 - 3 Midterm Exam Comprehensive Exam Study Guide Latest Updated 2024/2025 Professor question: What anti-arrhythmic medication in the reading this week requires pulmonary and thyroid function monitoring every 6 months?